Hysterectomy through the Smallest Incision Ever!
Dr. Marchand is an expert
award winning OBGYN
The Marchand Institute for Minimally Invasive Surgery is a research and educational not-for-profit corporation involved in the publication of high-quality medical research, expert level surgical education, and fulfillment of FDA Phase III Clinical Trials.
Dr. Marchand sets another World Record
Laparoscopic Ovarian Cancer Staging Surgery on the Largest Tumor: Arizona doctors set world record
A Research Institute First
The Marchand Institute is a 501(c)(3) non-profit research and educational institution. We produce peer-reviewed systematic reviews and meta-analyses in gynecologic surgery and women’s health at unusual volume — prospectively registered with PROSPERO, reported to PRISMA standards, and appraised with the Cochrane RoB 2 tool. We accept no pharmaceutical or medical device industry funding.
| 137 indexed publications |
1,200+ citations |
65 PROSPERO registrations |
8 FDA clinical trials |
190+ media citations |
Publications database · Our methodology · Research team · Clinical trials · Propose a collaboration
Journalists: Dr. Marchand is available for expert commentary and has been cited by Fox News, Medscape, STAT News, WebMD, Forbes Health, Newsmax, Scripps News and national broadcast affiliates of ABC, CBS and NBC. Contact Maria A. Sainz, Director of Communications and Media Relations, at maria@marchandobgyn.com or (480) 999-0905. → Newsroom & Press Kit · Expert topics · Coverage archive
Meet us this year: AAGL 2026 Global Congress, Boston, November 13–16 · SLS Minimally Invasive Surgery Week 2026, Orlando, December 2–5.
What People Are Saying About Dr. Marchand
“We congratulate Dr. Greg J. Marchand as SRC’s first Surgeon of Excellence in Minimally Invasive Surgery (SOEMIS) in the United States. To achieve SOEMIS accreditation, Dr. Marchand invited SRC to complete a rigorous onsite inspection and thorough chart review to illustrate his compliance with the program. Dr. Marchand and his practice exemplify SRC’s commitment to patient safety and care.”
Ashley DuBray, Senior Director, Surgical Review Corporation
In the News
All media appearances →Heavy Metal Contamination in Tampons: Reading the Evidence
Turn to Tara · April 6, 2026New Guidance on Acetaminophen Use During Pregnancy
The DMV Zone · September 23, 2025Hospital Affiliations
Dr. Marchand and the Institute’s surgeons hold active operating privileges at the following Arizona hospitals:
Latest Research
Marchand Institute Director Dr. Greg Marchand Named to the Fulbright Specialist Roster
Marchand Institute Director Greg J. Marchand, MD, FACS, FACOG, FICS has been named to the Fulbright Specialist Roster by the U.S. Department of State and World Learning, with a three year tenure running from August 14, 2026 through August 14, 2029.
Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
FOR IMMEDIATE RELEASE MESA, Ariz. — July 28, 2026 The Marchand Institute for Minimally Invasive Surgery is pleased to announce the online publication of our latest research, appearing today in the American Journal of Obstetrics & Gynecology MFM (AJOG MFM). Our new paper, titled “Single- versus Double-Layer Uterine Closure and Cesarean Scar Outcomes at Defined […]
Robotic vs. Non-Robotic Single-Site Hysterectomy: Marchand Institute’s New Meta-Analysis Provides Clarity on Surgical Outcomes
FOR IMMEDIATE RELEASE MESA, Ariz. — February 20, 2026 The Marchand Institute for Minimally Invasive Surgery is pleased to announce the online publication of our latest research, appearing today in the Journal of Gynecology Obstetrics and Human Reproduction (JOGOH). Our new paper, titled “Comparison of the Efficacy and Safety of Single-Site Laparoscopic Hysterectomy with and […]
Exciting News: Marchand Institute’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
FOR IMMEDIATE RELEASE MESA, Ariz. — February 5, 2026 We’re thrilled to announce that Dr. Marchand’s latest study has just been published in the Journal of the Turkish-German Gynecological Association (J Turk Ger Gynecol Assoc), and it’s freely available online today! The article, titled “Meta-analysis of changes in epithelial ovarian cancer incidence rates associated with salpingectomy: […]
New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
FOR IMMEDIATE RELEASE MESA, Ariz. — January 29, 2026 We are excited to announce our latest publication is now available online ahead of print in the American Journal of Perinatology! “Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery Versus Cesarean Section at Complete Dilation: A Systematic Review and Meta-Analysis.” is now available online […]
Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
FOR IMMEDIATE RELEASE MESA, Ariz. — January 1, 2026 We’re thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled “Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis”, this comprehensive […]